Catherine Hoffman
Internal Medicine · Gastonia, NCNPI 1215908561
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,251 and has fallen 98.2% since, to $23 in 2021.
Across 98 payments — averaging $15.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$291
- Amgen$195
- Sanofi-aventis U.S. LLC$147
- GSK$79
- AstraZeneca$78
- Lilly USA, LLC$72
- plus $643 from 23 others
What the payments were for
- Food & beverage$1,49399%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 18 | $291 |
| Amgen | 11 | $195 |
| Sanofi-aventis U.S. LLC | 10 | $147 |
| GSK | 5 | $79 |
| AstraZeneca | 6 | $78 |
| Lilly USA, LLC | 6 | $72 |
| Merck | 4 | $56 |
| Johnson & Johnson | 4 | $55 |
| Kowa Pharmaceuticals America, Inc. | 4 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $41 |
| Pfizer | 3 | $41 |
| Supernus Pharmaceuticals, Inc. | 2 | $39 |
| Rhodes Pharmaceuticals L.p. | 2 | $39 |
| Insulet Corporation | 1 | $33 |
| CSL Behring | 2 | $29 |
| Amarin Pharma, Inc. | 2 | $27 |
| Eisai Inc. | 2 | $26 |
| Shire North American Group Inc | 2 | $25 |
| Nevro Corp. | 1 | $23 |
| Abbott | 1 | $23 |
| Masimo Corporation | 1 | $21 |
| Genentech USA, Inc. | 1 | $16 |
| Adlon Therapeutics L.p. | 1 | $16 |
| Neos Therapeutics, LP | 1 | $15 |
| Vertical Pharmaceuticals, LLC | 1 | $15 |
| Boehringer Ingelheim | 1 | $15 |
| IBSA Pharma Inc. | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Seqirus USA Inc | 1 | $11 |
How this compares
$1,505 in reported general payments places this provider in the 80th percentile of 3,302 internal medicine providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol (Once Weekly)Estradiol | 18 | $1,120 |
| Np ThyroidThyroid,pork | 13 | $718 |
| ProgesteroneProgesterone, Micronized | 22 | $526 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Gastonia
- Stephen BurgessGastonia$240K
- Greg RobicheauxGastonia$38K
- Nirmish ShahDurham$862K
- Eugene WrightFayetteville$839K
- Saad UsmaniCharlotte$551K
- Bhakti PaulRaleigh$536K
- Mary KlotmanDurham$478K
- Manesh PatelDurham$435K
- Millie LongChapel Hill$374K
- Marc JohnsonCharlotte$342K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.